Keywords: pozen, submits, full, trexima, response, fda, north

Pozen submits full Trexima response to FDA

Article | 20 November 2006

Print This

North Carolina, USA-based drugmaker Pozen and UK pharmaceutical giant GlaxoSmithKline have submitted a full response to the Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in